C-MER Eye Care Holdings Limited AI Stock Analysis
Want to see HK:3309 full AI Analyst Report?
C-MER Eye Care Holdings Limited (3309) AI Stock Analysis
C-MER Eye Care Holdings Limited
(HKEX:3309)
The score is supported primarily by a strong balance sheet, improving cash generation, and reasonable valuation. Profitability volatility and mixed long-term technical positioning limit the upside, despite positive short-term momentum.
C-MER Eye Care Holdings Limited (3309) vs. iShares MSCI Hong Kong ETF (EWH)
- Market Cap
- HKD 1.16B
- Dividend Yield
- 3.08%
- Average Volume (3M)
- 469.65K
- Price to Earnings (P/E)
- 11.6
- Beta (1Y)
- 0.79
- Revenue Growth
- 4.75%
- EPS Growth
- ―
- Country
- Hong Kong
- Employees
- 2,200
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
C-MER Eye Care Holdings Limited Business Overview & Revenue Model
Company Description
C-MER Medical Holdings Limited specializes in offering both medical treatments and therapeutic services for a variety of eye conditions. Its business activities are segmented into two primary areas: the delivery of ophthalmological services and the r...
C-MER Eye Care Holdings Limited Financial Statement Overview
Summary
Strong balance-sheet stability and improving cash flow support the score, while revenue growth is offset by volatile profitability and inconsistent margins.
Income Statement
65PositiveBalance Sheet
82Very PositiveCash Flow
75Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.03B | 1.95B | 1.91B | 1.92B | 1.73B | 1.11B |
| Gross Profit | 633.13M | 603.67M | 527.62M | 618.96M | 365.34M | 309.44M |
| EBITDA | 373.27M | 341.37M | 343.30M | 363.38M | 194.31M | 177.80M |
| Net Income | 100.44M | 100.37M | -135.16M | 62.00M | -21.88M | 21.86M |
Balance Sheet | ||||||
| Total Assets | 2.86B | 2.73B | 2.72B | 2.75B | 2.90B | 1.96B |
| Cash, Cash Equivalents and Short-Term Investments | 563.37M | 465.96M | 467.25M | 557.42M | 698.51M | 442.36M |
| Total Debt | 433.61M | 426.78M | 437.79M | 362.99M | 452.49M | 471.69M |
| Total Liabilities | 868.58M | 796.01M | 830.24M | 755.35M | 903.45M | 618.63M |
| Stockholders Equity | 1.83B | 1.77B | 1.75B | 1.85B | 1.87B | 1.33B |
Cash Flow | ||||||
| Free Cash Flow | 323.23M | 223.94M | 124.50M | 245.30M | 100.63M | 19.18M |
| Operating Cash Flow | 400.23M | 301.47M | 283.12M | 361.15M | 191.86M | 148.41M |
| Investing Cash Flow | -45.70M | -169.66M | -174.72M | -245.37M | -210.65M | -392.72M |
| Financing Cash Flow | -196.81M | -212.38M | -194.92M | -242.88M | 293.68M | 85.12M |
C-MER Eye Care Holdings Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3309, the sentiment is Positive. The current price of 0.97 is above the 20-day moving average (MA) of 0.88, above the 50-day MA of 0.84, and below the 200-day MA of 1.06, indicating a neutral trend. The MACD of 0.04 indicates Negative momentum. The RSI at 66.97 is Neutral, neither overbought nor oversold. The STOCH value of 76.41 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:3309.
C-MER Eye Care Holdings Limited Peers Comparison
Overall Rating
HK:152679.2Outperform
HK:221973Outperform
HK:330970Outperform
HK:368964Neutral
HK:184652Neutral
HK:388648Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 79Outperform | HKD 1.35B | 3.83 | 17.86% | 2.35% | 1.25% | 12.60% | |
| 73Outperform | HKD 1.68B | 8.48 | 6.97% | 10.14% | 3.85% | -1.23% | |
| 70Outperform | HKD 1.20B | 11.58 | 5.57% | 3.08% | 4.75% | ― | |
| 64Neutral | HKD 601.91M | 5.28 | 6.35% | 10.56% | -0.27% | 29.73% | |
| 52Neutral | HKD 671.52M | 272.73 | 0.20% | 2.10% | 20.54% | -96.74% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 48Neutral | HKD 1.22B | 86.19 | 0.48% | 1.00% | -3.26% | ― |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HK:3309 | C-MER Eye Care Holdings Limited | 0.97 | -0.77 | -44.13% | |
| HK:1526 | Rici Healthcare Holdings Ltd. | 0.85 | -0.11 | -11.27% | |
| HK:1846 | EuroEyes International Eye Clinic Limited | 2.10 | -1.14 | -35.25% | |
| HK:2219 | Chaoju Eye Care Holdings Ltd. | 2.39 | 0.10 | 4.14% | |
| HK:3689 | Guangdong Kanghua Healthcare Co., Ltd. Class H | 1.80 | 0.10 | 5.70% | |
| HK:3886 | Town Health International Medical Group Ltd. | 0.18 | -0.08 | -31.30% |
C-MER Eye Care Holdings Limited Corporate Events
C-MER Medical Posts Higher Revenue but Softer Adjusted Profit in First Half of 2026
C-MER Medical Holdings Limited reported unaudited interim results for the six months ended 30 June 2026, showing revenue of HK$1,024.4 million, up 8.5% year on year. Gross profit rose 10.0% to HK$323.4 million and gross margin improved slightly to 31...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 07, 2026
